Zoono Group Stock

Zoono Group Equity

The The Equity of Zoono Group (ZNO.AX) as of Aug 7, 2026 is 3.21 M NZD. In the previous year, The Equity was 6.82 M NZD — a change of -52.93% (lower).

Equity

3.21 MNZD

YoY

-52.93%

Last updated:

In 2026, Zoono Group's equity was 3.21 M NZD, a -52.93% increase from the 6.82 M NZD equity in the previous year.

Access this data via the Eulerpool API

Zoono Group Stock analysis

What does Zoono Group do? The Zoono Group Ltd is a globally operating company that develops and distributes antimicrobial solutions. The company was founded in New Zealand in 2009 and now has branches and distribution partners in Australia, USA, Canada, Europe, Asia, and South Africa. The business model of Zoono is based on the development and marketing of antimicrobial solutions for use in various industries, such as healthcare, food industry, animal husbandry, and public buildings. The goal of Zoono is to provide a safe and effective alternative to conventional cleaning and disinfection methods. Zoono's products contain special molecules that adhere to surfaces and form a barrier against bacteria, viruses, fungi, and algae. Some of Zoono's products include hand disinfectants, surface disinfectants, air purifiers, and pet care products. The company places a strong emphasis on ensuring that these products are non-toxic, biodegradable, and environmentally friendly. Zoono's solutions have already proven themselves in various industries. For example, they are successfully used in the food industry to prevent the growth of bacteria and mold. The products are also used in healthcare settings because of their long-lasting effectiveness, reducing the risk of infections. In addition to antimicrobial solutions, Zoono also offers consulting services. The company develops individual solutions for customers and adapts the products to meet specific requirements and needs. Thanks to the high effectiveness of their products, extensive network of partners and customers, and constant innovation of new solutions, Zoono has established itself as a successful and forward-thinking company in the industry. In conclusion, the Zoono Group Ltd is an innovative and internationally operating company specializing in the development and marketing of antimicrobial solutions. Their business model is based on the development of safe and effective alternatives to conventional cleaning and disinfection methods. Thanks to the high effectiveness of their products and extensive network of partners and customers, Zoono has established itself as a leading provider in the industry. Zoono Group is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Zoono Group's Equity

Zoono Group's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Zoono Group's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Zoono Group's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Zoono Group's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Zoono Group’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Zoono Group stock

The Equity of Zoono Group is 3.21 M NZD in 2026.

The Equity of Zoono Group changed from 6.82 M NZD to 3.21 M NZD, representing a -52.93% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity Zoono Group since 2006 – with annual values, charts, and detailed analysis.

The Equity's NZD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Zoono Group historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Zoono Group

All Key Metrics — Zoono Group